RT Journal Article
SR Electronic
A1 Spevak, Aimee
T1 SAPIEN 3 TAVR System Produces Excellent Clinical Outcomes in PARTNER II Trial
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 5
SP 13
OP 14
DO 10.1177/1559897715583829
UL http://mdc.sagepub.com/content/15/5/13.2.abstract
AB The PARTNER II trial investigated the use of the SAPIEN 3 transcatheter aortic valve replacement in patients who were high-risk/inoperable or intermediate-risk for surgical complications. Clinical outcomes were excellent, with low rates of adverse events and paravalvular leak.